Test methods for predicting tardive toxicity of therapeutic drugs using laboratory animals

Journal of Toxicological Sciences

Volumn 21, Issue 1, 1996, Pages 105-107

  Ando, Kiyoshi ^a  

^a Preclin Research Laboratories Inc ^*  (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; CLOZAPINE; DOPAMINE RECEPTOR; HALOPERIDOL; METHAMPHETAMINE; NEUROLEPTIC AGENT; THIORIDAZINE;

CONFERENCE PAPER; DOPAMINERGIC SYSTEM; EXPERIMENTAL ANIMAL; LEARNING DISORDER; MONKEY; SIGNAL TRANSDUCTION; TARDIVE DYSKINESIA;

ANIMALIA;

EID: 0029877603     PISSN: 03881350     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.21.105     Document Type: Conference Paper

References (5)

1. Baldessarini, R. J. (1990) : Drugs and the treatment of psychiatric disorders. In Goodman and Oilman's The Pharmacological Basis of Therapeutics, Eighth Edition (Goodman Gilman, A. et al., eds.), pp. 383-435, Pergamon Press, New York.
2. Casey, D. E. (1987): Tardive dyskinesia. In Psychopharmacology : The Third Generation of Progress (Meltzer, H. Y., ed.), pp. 1411-1419, Raven Press, New York.
3. DSM-III-R, Diagnostic and statistical manual of mental disorders (Third edition-revised) (1987) : American Psychiatric Association, Washington, D. C.
4. Gunne, L-M. and Barany, S. (1979) : A monitoring test for the liability of neuroleptic drugs to induce tardive dyskinesia. Psychopharmacology, 63, 195-198.
5. Yanagita, T., Shimada, A., Hironaka, N. and Yamaguchi, K. (1995) : Comparative study on the psychotoxicity of drugs of abuse and nicotine. Smoking Research Foundation, Annual Research Report 1994, 757-762 (in Japanese with English abstract).